The “AIG effect” has hit the pharmaceutical meetings sector. During a closed-door summit for senior-level corporate planners at the Pharmaceutical Meeting Management Forum, participants pointed out that although the pharmaceutical industry is way ahead of the curve in terms of implementing business practices in meetings, the public perception of incentives and corporate events is spilling over into the medical niche. In addition to the perception issue, pharmaceutical companies face
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments